Sign Up | Log In | What is SocialPicks?

1 pt

Opinion on Neurobiological Technologies Inc. (NTII) Sector: Healthcare > Industry: Biotechnology & Drugs
biotech 20 dollars or 1

Aug 03, 2007 01:03 AM GMT

Jason Halverson

Return	Risk
-71.82%	HIGH

Analyst

Profile & Performance

Subscribe to author

Home run stock. Nuroscience drug stock. 20 million + invested. Testing over next 8 months in liver trials. positive progress 12 dollars, downside 1 dollar. Great entry point. Best risk reward opportunity on market.

NTII: This call was made on 08/03/07 @ $1.47

Rating:	$1.47 (08/03/07)
Gain/Loss:	-85.37% in 842 days
Target:	$12.00 (+716.33%) in > one year
Allocation:	7.6% of portfolio

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	378
2	Gerald Greene	18.14	+70.10%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.30%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
WM	Washington Mutual Inc
GM	General Motors Corp
T	AT&T Inc
LEH	Lehman Brothers Holdings Inc
GS	Goldman Sachs Group Inc The
PG	The Procter & Gamble Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla
DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla
CERS		BioMed News Bytes: GeoVax, Cerus, Discovery Labs by Mike Havrilla

... more »

Neurobiological Technologies Inc. (NTII)

SocialPicks Sentiment: N/A

This Quarter's Sentiment:

All:

100.0%

Top:

0.0%

Get Daily Email Alerts

Subscribe to Jason Halverson

Receive Free Ideas Daily for This Sector

Latest Picks by Jason Halverson

Symbol	SP Sentiment	Return	Since
GROW		-39.55%	08/03/07
DJ		n/a	08/03/07
PPDA	N/A	-88.73%	08/03/07
ETFC		-90.53%	08/03/07

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Neurobiological Technologies Inc. (NTII) Sector: Healthcare > Industry: Biotechnology & Drugs biotech 20 dollars or 1

Opinion on Neurobiological Technologies Inc. (NTII) Sector: Healthcare > Industry: Biotechnology & Drugs
biotech 20 dollars or 1